相关实验视频

Updated: Jul 5, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

个人阿尔法峰值预测了TMS治疗抑郁症的临床反应:一个独立的复制

Mate Baradits¹, Andrew Spitzberg², Ashkhan J Davani³

¹Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY 11004, USA; Institute of Behavioral Science, Feinstein Institutes for Medical Reasearch, Manhasset, NY 11030, USA; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.

Psychiatry research

|November 19, 2025

概括

个人阿尔法峰值频率 (iAF) 预测了重复性跨磁刺激 (rTMS) 对主要抑郁症 (MDD) 失调症状的反应,特别是在女性中. iAF没有预测焦虑症症状的改善.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
生物标志物生物标志物

背景情况:

重复性横磁性刺激 (rTMS) 是主要抑郁症 (MDD) 的关键治疗方法.
预测个人对rTMS的反应仍然是一个挑战.
个体阿尔法峰值频率 (iAF) 显示出作为rTMS结果预测生物标志物的潜力.

研究的目的:

调查iAF作为MDD中rTMS治疗反应的预测生物标志物的实用性.
为了检查iAF是否能够预测特异性和焦虑症症状领域的响应.
探索IAF预测能力中的潜在性别差异.

主要方法:

对27名MDD患者进行了5周的左背侧前额皮层 (DLPFC) 10 Hz rTMS.的分析.
基线脑电图 (EEG) 用于计算iAF及其接近刺激频率 (iAF_dist).
评估特定领域的临床症状改善 (失调性和焦虑性).

主要成果:

iAF显著预测了异常症状的改善,但不是焦虑症症状.
在女性患者中,rTMS治疗效应更为明显.
探索性分析 (n=121) 证实女性的IAF预测效用更强.

结论:

iAF是预测MDD中rTMS反应的有希望的生物标志物,特别是对于失调症状.
iAF的预测值可能会受到临床症状领域和患者性别的影响.
需要进一步的研究来阐明性别特异性机制,并优化基于IAF的治疗选择.

关键词:

抑郁症抑郁症抑郁症这是一个EEGEEGEEGEEGEEGEEGEEG.个别的阿尔法峰值.rTMS的使用情况.

更多相关视频

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...